Premium
Regression of hepatocellular adenomas and systemic inflammatory syndrome after cessation of estrogen therapy
Author(s) -
Sinclair Marie,
Schelleman Anthony,
Sandhu Daljean,
Angus Peter W.
Publication year - 2017
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.29151
Subject(s) - medicine , pill , estrogen , adenoma , systemic inflammation , gastroenterology , inflammation , estrogen therapy , systemic therapy , endocrinology , oncology , cancer , pharmacology , breast cancer
We report a case of dramatic systemic inflammatory symptoms and biochemical signs of inflammation related to multiple hepatic adenomas that completely resolved after cessation of the oral contraceptive pill (OCP) and associated adenoma regression. This represents a case of dramatic symptoms that resolved after estrogen withdrawal alone. (H epatology 2017;66:989–991).